Try GOLD - Free
Weight loss cure Mounjaro is India's new drug market king
Mint Mumbai
|November 08, 2025
Drug unseats the previous best-selling antibiotic Augmentin, which had sales of ₹80 crore
Sales of Eli Lilly’s blockbuster weight-loss drug Mounjaro have soared in India, making it the top-selling brand in October, just six months after its launch in the world's most populous nation.
The drug registered sales of ₹100 crore in October, unseating the previous bestselling antibiotic Augmentin, which recorded sales of ₹80 crore during the month, according to data from intelligence platform Pharmarack on Friday. Since its launch late in March 2025, Mounjaro's total sales have reached ₹333 crore.
Augmentin, the London-headquartered GSK’s broad-range antibiotic, still retains its top position on a moving annual total (MAT) basis, with sales of ₹863 crore in 12 months to October 2025. MAT refers to total sales seen over the latest 12-month period.
This marks Eli Lilly's sharp capture of India’s nascent anti-obesity market, outpacing competitor Novo Nordisk. ‘The brand took the second spot in sales in September, Pharmarack data showed.
This story is from the November 08, 2025 edition of Mint Mumbai.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Mumbai
Mint Mumbai
DRONES TEST DUBAI REAL ESTATE RESILIENCE
The city-state’s realty market tore into 2026 on a four-year boom—until Iran’s drones and missiles iced it
8 mins
May 15, 2026
Mint Mumbai
JSW Steel raises capacity target sharply amid strong FY26 show
Sajjan Jindal-led JSW Steel plans to nearly double its capacity to about 80 million tonnes per annum (mtpa) by 2031 through aggressive brownfield expansion and joint ventures, positioning India’s largest steelmaker among the world’s biggest producers.
2 mins
May 15, 2026
Mint Mumbai
Air India’s FY26 loss nears $3 billion amid headwinds
Air India posted an estimated loss of nearly $3 billion in FY26, as foreign exchange losses, airspace disruptions and elevated fuel costs battered the Tata Group-owned airline during the year.
3 mins
May 15, 2026
Mint Mumbai
Bond yield surge dents PSU banks’ non-core income
Rising government bond yields hit banks’ treasury income in the March quarter (Q4FY26), dragging down non-core earnings, especially at public sector lenders. Analysts now expect the pressure to intensify in the June quarter after an oil-driven spike in bond yields following the West Asia conflict.
3 mins
May 15, 2026
Mint Mumbai
FMCG firms begin hiking prices as war hits input costs
Consumer goods makers are raising prices and bracing for weaker demand as commodity inflation spreads across fuel, packaging and food inputs.
3 mins
May 15, 2026
Mint Mumbai
Oil calm as Trump, Xi meet amid strife
Fresh attacks on vessels in Gulf underscore fragility of ceasefire
3 mins
May 15, 2026
Mint Mumbai
Big tech’s fat profits conceal unsettling cashflows
A chart is haunting Silicon Valley. The profits of big cloud-computing firms (Amazon, Google, Meta, Microsoft and Oracle) are rising inexorably. Yet the amount of cashflow they generate after capital spending is falling. Sketched together, these soaring profits and diving free cashflows, which until recently rose in unison, resemble the gasps of the world’s investors.
4 mins
May 15, 2026
Mint Mumbai
Cement firms turn defensive as war shock spikes costs
Cement makers are responding with fuel substitution, long-term sourcing contracts
3 mins
May 15, 2026
Mint Mumbai
Tata Motors PV revenue dips
The firm posted its first annual revenue decline in five years and a FY26 operating loss, hurt by JLR headwinds
3 mins
May 15, 2026
Mint Mumbai
ASK launches ₹2,500-cr 2nd pvt credit fund
ASK Alternates, part of the Blackstone-backed ASK Asset & Wealth Management Group, launched its second private credit fund with a target corpus of ₹2,500 crore, including a ₹1,500 crore green-shoe option, a top executive at the company said.
1 min
May 15, 2026
Listen
Translate
Change font size